Journal info
|
||||
Select Journal
Journals
Acta Virologica Bratislava Medical Journal Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.116, No.12, p.746-750, 2015 |
||
Title: The effects of low and high doses of sugammadex on kidney tissue in streptozotocin-induced diabetic rats | ||
Author: G. Kip, H. C. Turgut, M. Alkan, M. E. Aydin, M. E. Erbatur, H. A. Kiraz, S. Kartal, H. Boyunaga, F. M. Comu, O. Erdem, M. Arslan, Y. Unal | ||
Abstract: BACKGROUND: Sugammadex is primarily excreted via renal route. We investigated effects of low and high doses of sugammadex (16 mg/kg versus 96 mg/kg) on renal tissue samples of streptozotocin-induced diabetic rats. MATERIAL AND METHODS: Twenty-four Wistar albino rats were divided into 4 groups. Group C (control – 0.9 % NaCl), Group DC (diabetes control; 55 mg/kg streptozotocin, IP, only), Group DR-16S (diabetes-rocuronium – 16 mg sugammadex, IV.) and Group DR-96S (diabetes- rocuronium – 96 mg sugammadex, IV). Renal tissue histopathological evaluation and antioxidant status (measurements of MDA levels and NO activities) were studied. RESULTS: Significantly higher levels of all inflammation parameters (inflammation, degeneration/necrosis, tubular dilatation, tubular cell degeneration, dilatation in Bowman’s space, tubular hyaline casts, and lymphocyte infiltration) were found in the 96 mg/kg sugammadex group. Higher MDA tissue levels and lower NO activity were found in the 96 mg/kg sugammadex group. DISCUSSION: We can conclude that high-dose (96 mg/kg) sugammadex administration resulted in significant renal tissue damage in diabetic rats. As a consequence, low doses of sugammadex have to be preferred in diabetic patients (Tab. 2, Fig. 4, Ref. 26). |
||
Keywords: sugammadex, streptozotocin, diabetes, renal damage. | ||
Published online: 15-Dec-2015 | ||
Year: 2015, Volume: 116, Issue: 12 | Page From: 746, Page To: 750 | |
doi:10.4149/BLL_2015_146 |
||
|
![]() |
|